Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
blonanserin | dopamine d2 receptor | small molecule | Successful target | TTD , drugbank , DGIDB | Schizophrenia[MeSHID:D012559] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.54 | investigational,phase 3 | antagonist |
blonanserin | dopamine d3 receptor | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | investigational | antagonist |
blonanserin | 5-hydroxytryptamine receptor 2a | small molecule | NA | drugbank , DGIDB | Schizophrenia[MeSHID:D012559] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.65 | investigational | antagonist |
blonanserin | 5-ht 2a receptor | NA | Successful target | TTD , DGIDB | Schizophrenia[MeSHID:D012559] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.65 | phase 3 | antagonist |
blonanserin | 5-ht 2a receptor | NA | Successful target | TTD , DGIDB | Schizophrenia[MeSHID:D012559] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.65 | phase 3 | unknown |
click here to return to the previous page |